Abstract is: Keith Humphreys (born 1966 in West Virginia) is an American psychologist currently the Esther Ting Memorial Professor at Stanford University, a Senior Research Career Scientist in the Veterans Health Administration, and an Honorary Professor at the Institute of Psychiatry, King's College, London. His scholarship has focused on addiction, veterans' health, self-help groups for chronic diseases, electronically delivered mental health treatments, and the extent to which samples in treatment research differ from real-world patients in everyday clinical practice. He has published over 350 peer-reviewed articles and his work has been cited over 18,000 times. He is The Deputy Editor in Chief for the journal Addiction. Humphreys won the 2021 Under Secretary's Award for Outstanding Achievement in Health Services Research from the U.S. Department of Veterans Affairs.
| human | Q5 |
| P646 | Freebase ID | /m/0c57fqj |
| P1960 | Google Scholar author ID | UIfCccUAAAAJ |
| P269 | IdRef ID | 083373632 |
| P6005 | Muck Rack journalist ID | keith-humphreys |
| P8189 | National Library of Israel J9U ID | 987007454910005171 |
| P1207 | NUKAT ID | n2018244824 |
| P496 | ORCID iD | 0000-0003-0694-5761 |
| P8743 | Scholars Strategy Network ID | keith-humphreys |
| P1153 | Scopus author ID | 35268983500 |
| P7943 | The Washington Post contributor ID | keith-humphreys |
| P214 | VIAF ID | 31220155 |
| P7859 | WorldCat Identities ID (superseded) | lccn-n94008611 |
| P1556 | zbMATH author ID | humphreys.keith |
| P1416 | affiliation | Stanford University | Q41506 |
| P6424 | affiliation string | Stanford University | |
| P27 | country of citizenship | United States of America | Q30 |
| P1889 | different from | Keith Humphreys | Q115254199 |
| P108 | employer | Stanford University | Q41506 |
| King's College London | Q245247 | ||
| P734 | family name | Humphreys | Q16870922 |
| Humphreys | Q16870922 | ||
| Humphreys | Q16870922 | ||
| P735 | given name | Keith | Q1159033 |
| Keith | Q1159033 | ||
| P6872 | has written for | The Washington Post | Q166032 |
| P1412 | languages spoken, written or signed | English | Q1860 |
| P6104 | maintained by WikiProject | WikiProject Mathematics | Q8487137 |
| P106 | occupation | psychologist | Q212980 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P1344 | participant in | World Economic Forum Annual Meeting 2016 | Q114717232 |
| P21 | sex or gender | male | Q6581097 |
| Q33848895 | 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy |
| Q62583374 | A Combined Segmentation and Registration Framework for Bilateral and Temporal Mammogram Analysis |
| Q54703474 | A Review of the Impact of Exclusion Criteria on the Generalizability of Schizophrenia Treatment Research. |
| Q46154156 | A call to include people with mental illness and substance use disorders alongside 'regular' smokers in smoking cessation research |
| Q42676622 | A combined analysis of genome-wide association studies in breast cancer |
| Q35311162 | A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival |
| Q52285364 | A few apologies, but no regrets. |
| Q34613513 | A genome-wide association scan on estrogen receptor-negative breast cancer |
| Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q34425597 | A meta-analysis of genome-wide association studies of follicular lymphoma |
| Q44334722 | A pilot cohort study of the determinants of longitudinal opioid use after surgery |
| Q37883481 | A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients |
| Q35870483 | A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients |
| Q57148458 | A public health approach to opioid addiction in North America - Author's reply |
| Q37436939 | A randomized trial of a mental health consumer-managed alternative to civil commitment for acute psychiatric crisis |
| Q38222103 | A review of the impact of exclusion criteria on the generalizability of schizophrenia treatment research |
| Q57388305 | A revised checklist for writing up research reports |
| Q46116445 | A statistical model of breast cancer tumour growth with estimation of screening sensitivity as a function of mammographic density |
| Q51762544 | A stochastic EM type algorithm for parameter estimation in models with continuous outcomes, under complex ascertainment. |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q52304443 | Action is needed to deter the trumpeting of non-peer-reviewed findings to the media. |
| Q40389298 | Adapting a computer-delivered brief alcohol intervention for veterans with Hepatitis C. |
| Q52311581 | Addiction Debates: challenging ideas, challenging ourselves. |
| Q36766895 | Addiction Treatment Professionals Are Not the Gatekeepers of Recovery |
| Q48073992 | Addiction editors respond to Mr. Leverton |
| Q60941311 | Addiction's priorities when evaluating submissions |
| Q34193412 | Alcohol & drug abuse: A research-based analysis of the Moderation Management controversy |
| Q28183641 | Alcoholics Anonymous and 12-step alcoholism treatment programs |
| Q46150667 | Alcoholics Anonymous involvement and positive alcohol-related outcomes: Cause, consequence, or just a correlate? A prospective 2-year study of 2,319 alcohol-dependent men |
| Q46180606 | An Overdose Antidote Goes Mainstream |
| Q89037495 | An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain |
| Q33232849 | Analysis of binary traits: testing association in the presence of linkage |
| Q42635439 | Ancestral recombination graphs under non-random ascertainment, with applications to gene mapping |
| Q34374548 | Area and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer |
| Q43976953 | Assessing spirituality/religiosity in the treatment environment: the Treatment Spirituality/Religiosity Scale |
| Q35922938 | Assessing understandings of substance use disorders among Norwegian treatment professionals, patients and the general public |
| Q58088831 | Assessing why substance use disorder patients drop out from or refuse to attend 12-step mutual-help groups: The “REASONS” questionnaire |
| Q28364715 | Assessing within-woman changes in mammographic density: a comparison of fully versus semi-automated area-based approaches |
| Q50986912 | Assessment of lead-time bias in estimates of relative survival for breast cancer. |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q33647358 | Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis |
| Q37691149 | Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment |
| Q60928337 | Association of Neural Responses to Drug Cues With Subsequent Relapse to Stimulant Use |
| Q57027120 | Associations between Androgen and Vitamin D Receptor Microsatellites and Postmenopausal Breast Cancer |
| Q41080132 | Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q40206782 | Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment |
| Q42007003 | Avoiding globalisation of the prescription opioid epidemic |
| Q47277263 | Benefit requirements for substance use disorder treatment in state health insurance exchanges |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q47847427 | Brains, environments, and policy responses to addiction |
| Q40055436 | Breast Tissue Organisation and its Association with Breast Cancer Risk |
| Q36393193 | Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q30988479 | Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data |
| Q25257428 | CYP17 gene polymorphism in relation to breast cancer risk: a case-control study |
| Q34087449 | Can targeting nondependent problem drinkers and providing internet-based services expand access to assistance for alcohol problems? A study of the moderation management self-help/mutual aid organization |
| Q37689779 | Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study |
| Q40497787 | Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients |
| Q39388549 | Clinical depression, antidepressant use and risk of future cardiovascular disease |
| Q52289857 | Closing remarks: Swimming to the horizon--reflections on a special series. |
| Q37010368 | Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk |
| Q35558033 | Coffee consumption modifies risk of estrogen-receptor negative breast cancer |
| Q92411330 | Commentary on Burke et al. (2020): Safer and less-frequent opioid prescribing are both essential for US public health |
| Q48476671 | Commentary on Gustafson et al. (2013): can we know that addiction treatment has been improved without evidence of better patient outcomes? |
| Q37177879 | Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival |
| Q52582441 | Common genetic variation and novel loci associated with volumetric mammographic density. |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q33918347 | Common shared genetic variation behind decreased risk of breast cancer in celiac disease |
| Q28364712 | Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk |
| Q30478981 | Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study |
| Q99409589 | Computer-Delivered Brief Alcohol Intervention for Patients with Liver Disease: A Randomized Controlled Trial |
| Q34594697 | Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant |
| Q44335633 | Consistent adherence to guidelines improves opioid dependent patients' first year outcomes |
| Q39825094 | Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States |
| Q53091407 | Cross-level bias and variations in care. |
| Q47780480 | Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk |
| Q52308193 | Data Notes Series. |
| Q46416745 | Datapoints: do participants in alcoholism treatment outcome studies resemble patients seen in everyday practice? |
| Q53666938 | Datapoints: moving from inpatient to residential substance abuse treatment in the VA. |
| Q44945809 | Depression increases diabetes symptoms by complicating patients' self-care adherence |
| Q36446470 | Despite Resources From The ACA, Most States Do Little To Help Addiction Treatment Programs Implement Health Care Reform |
| Q25255226 | Determining effective methadone doses for individual opioid-dependent patients |
| Q43269999 | Developing and validating process measures of health care quality: an application to alcohol use disorder treatment |
| Q44333730 | Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems |
| Q37730862 | Distribution of Opioids by Different Types of Medicare Prescribers |
| Q30764470 | Do clinical trials of treatment of alcohol dependence adequately enroll participants with co-occurring independent mood and anxiety disorders? An analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). |
| Q51903716 | Does following research-derived practice guidelines improve opiate-dependent patients' outcomes under everyday practice conditions? Results of the Multisite Opiate Substitution Treatment study. |
| Q46390635 | Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes? |
| Q46307104 | Does writing affect asthma? A randomized trial |
| Q37958888 | Dopamine, working memory, and training induced plasticity: implications for developmental research |
| Q59768608 | Drug Policy and the Public Good |
| Q37973813 | Drug policy and the public good: evidence for effective interventions |
| Q38371172 | E-Science technologies in a workflow for personalized medicine using cancer screening as a case study |
| Q36643091 | ESR1 and EGF genetic variation in relation to breast cancer risk and survival |
| Q46124116 | Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial |
| Q33889541 | Effects of childhood body size on breast cancer tumour characteristics |
| Q46110766 | Electronic support groups for breast carcinoma: a clinical trial of effectiveness |
| Q43694294 | Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes |
| Q37377626 | Enhancement of mammographic density measures in breast cancer risk prediction |
| Q34449320 | Estimating the efficacy of Alcoholics Anonymous without self-selection bias: an instrumental variables re-analysis of randomized clinical trials |
| Q30850668 | Estrogen receptor alpha gene polymorphism and endometrial cancer risk--a case-control study |
| Q58085898 | Evaluating dynamic impacts of abuse-deterrent prescription opioid formulations |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q41305410 | Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders |
| Q36717500 | Excellent Patient Care Processes in Poor Hospitals? Why Hospital-Level and Patient-Level Care Quality-Outcome Relationships Can Differ |
| Q52562484 | Exclusion criteria and generalizability in bipolar disorder treatment trials. |
| Q38871274 | Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis |
| Q46145820 | Extending Addiction's conflict of interest policy to cover the emerging cannabis industry |
| Q42057785 | Extending the benefits of addiction treatment: practical strategies for continuing care and recovery |
| Q37658282 | Extent and reporting of patient nonenrollment in influential randomized clinical trials, 2002 to 2010. |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q52300166 | Federal policy on criminal offenders who have substance use disorders: how can we maximize public health and public safety? |
| Q51911933 | Fine mapping of disease genes using tagging SNPs. |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q33232827 | Fine-scale mapping in case-control samples using locus scoring and haplotype-sharing methods |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q34998732 | Formative evaluation and three-month follow-up of an online personalized assessment feedback intervention for problem drinkers |
| Q58143558 | Fourth and Fifth Step Groups: A New and Growing Self-Help Organization for Underserved Latinos with Substance Use Disorders |
| Q89693567 | From "Step Away" to "Stand Down": Tailoring a Smartphone App for Self-Management of Hazardous Drinking for Veterans |
| Q52287632 | From addiction treatment research reviews to better widgets. |
| Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
| Q28748267 | GENESTAT: an information portal for design and analysis of genetic association studies |
| Q33886166 | GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma |
| Q51013455 | Gains in fluid intelligence after training non-verbal reasoning in 4-year-old children: a controlled, randomized study. |
| Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
| Q28481918 | Genetic variants in ER cofactor genes and endometrial cancer risk |
| Q44422424 | Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q57568320 | Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators |
| Q33889494 | Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer |
| Q35029543 | Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q34033939 | Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q48828181 | Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries. |
| Q48058198 | Grappling with the generalizability crisis in addiction treatment research |
| Q48036707 | Griffith Edwards' rigorous sympathy with Alcoholics Anonymous |
| Q53500290 | HEDIS initiation and engagement quality measures of substance use disorder care: impact of setting and health care specialty. |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q36924460 | High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer |
| Q40302580 | How ACA Repeal Would Worsen the Opioid Epidemic |
| Q37742664 | How Internet technology can improve the quality of care for substance use disorders |
| Q53578686 | How are substance use disorders addressed in VA psychiatric and primary care settings? Results of a national survey. |
| Q47872263 | How to Deliver a More Persuasive Message Regarding Addiction as a Medical Disorder |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q35848934 | Identification of two novel mammographic density loci at 6Q25.1. |
| Q45330602 | If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration |
| Q40165940 | Improving Medicare coverage of psychological services for older Americans |
| Q37743712 | Ineligibility and refusal to participate in randomised trials of treatments for drug dependence |
| Q46261355 | Influence of subject eligibility criteria on compliance with National Institutes of Health guidelines for inclusion of women, minorities, and children in treatment research |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q58258133 | Inquirers, triers, and buyers of an alcohol harm reduction self-help organization |
| Q46489908 | Internet and paper self-help materials for problem drinking: is there an additive effect? |
| Q57163339 | Internet searches for opioids predict future emergency department heroin admissions |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q58170829 | Is addiction's collateral damage culturally invariant? |
| Q51151847 | It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q31012975 | Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecification |
| Q52288636 | Knitting together some ripping yarns. |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q34158058 | Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size |
| Q64410557 | Life Stories of Moderation Management Mutual Help Group Members |
| Q33242074 | Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk |
| Q38307606 | Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity |
| Q61445357 | Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study |
| Q54730200 | Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening. |
| Q40586607 | Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q51843302 | Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach. |
| Q33739464 | Mammographic density and survival in interval breast cancers |
| Q36916765 | Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer |
| Q61068250 | Mandatory sobriety programmes for alcohol-involved criminal offenders |
| Q45331713 | Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure |
| Q48237704 | Measuring working memory capacity with greater precision in the lower capacity ranges |
| Q64944488 | Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act. |
| Q52583069 | Medical Marijuana Users are More Likely to Use Prescription Drugs Medically and Nonmedically. |
| Q46109180 | Medicare Recipients' Use Of Medical Marijuana |
| Q34306652 | Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q34123806 | Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls |
| Q91588785 | Mitigating and learning from the impact of COVID-19 infection on addictive disorders |
| Q48364755 | Modelling breast cancer tumour growth for a stable disease population. |
| Q40597509 | Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes |
| Q33628755 | Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q37235124 | Mutual help groups for mental health problems: a review of effectiveness studies |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q33642714 | NordicDB: a Nordic pool and portal for genome-wide control data |
| Q35625800 | Normative misperceptions about alcohol use in a general population sample of problem drinkers from a large metropolitan city |
| Q37316377 | Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study |
| Q24806337 | Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study |
| Q47700154 | Of moral judgments and sexual addictions |
| Q53028429 | On informative detection bias in screening studies. |
| Q36430473 | Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. |
| Q48678348 | Organizational contexts of primary care approaches for managing problem drinking. |
| Q53450635 | Our Other Prescription Drug Problem. |
| Q42793293 | Our map should correspond with the territory |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q36446710 | Pain Duration and Resolution following Surgery: An Inception Cohort Study |
| Q38549829 | Participant exclusion criteria in treatment research on neurological disorders: Are unrepresentative study samples problematic? |
| Q44377092 | Participation in alcoholics anonymous: intended and unintended change mechanisms |
| Q40271968 | Pectoral muscle attenuation as a marker for breast cancer risk in full-field digital mammography |
| Q45331480 | Performance monitoring of substance use disorder interventions in the Veterans Health Administration |
| Q39294231 | Personality and psychopathology in African unaccompanied refugee minors: repression, resilience and vulnerability |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q37691217 | Possible influence of mammographic density on local and locoregional recurrence of breast cancer |
| Q64116861 | Predicting inadequate postoperative pain management in depressed patients: A machine learning approach |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q38914912 | Predictive Validity of Outpatient Follow-up After Detoxification as a Quality Measure |
| Q38840000 | Predictive validity of a quality measure for intensive substance use disorder treatment |
| Q36354144 | Predictive validity of two process-of-care quality measures for residential substance use disorder treatment |
| Q35857936 | Predictors of attrition from a national sample of methadone maintenance patients |
| Q46733509 | Predictors of retention in methadone programs: a signal detection analysis |
| Q36243356 | Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. |
| Q40411199 | Prevention of peer rejection through a classroom-level intervention in middle school |
| Q36812134 | Promoting recovery in an evolving policy context: what do we know and what do we need to know about recovery support services? |
| Q47645183 | Psychologists' ethical responsibilities in the Internet-based groups: Issues, strategies, and a call for dialogue |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q51913565 | Rebuilding Iraq's mental health system. |
| Q57173369 | Reconciling the Present and the Future in Opioid Prescription Policy: An Ethical Dilemma |
| Q48130275 | Recovery-oriented policy and care systems in the UK and USA. |
| Q93147934 | Reducing the risks of distortion in cannabis research |
| Q37278696 | Representativeness of patients enrolled in influential clinical trials: a comparison of substance dependence with other medical disorders. |
| Q43733163 | Responding to rising substance misuse in Iraq |
| Q45331296 | Responding to the psychological impact of war on the Iraqi people and U.S. veterans: mixing icing, praying for cake |
| Q46112128 | Response to methadone maintenance treatment of opiate dependent patients with and without significant pain |
| Q33774959 | Response: the marriage of drug abuse treatment and 12-step strategies |
| Q41488290 | Risk factors and tumor characteristics of interval cancers by mammographic density |
| Q48722074 | Scientific evidence alone is not sufficient basis for health policy. |
| Q35738035 | Self-help organizations for alcohol and drug problems: toward evidence-based practice and policy |
| Q33851745 | Self-loathing aspects of depression reduce postoperative opioid cessation rate |
| Q51870491 | Sensitivity analysis for principal stratum direct effects, with an application to a study of physical activity and coronary heart disease. |
| Q33878070 | Should patients' religiosity influence clinicians' referral to 12-step self-help groups? Evidence from a study of 3,018 male substance abuse patients |
| Q90234628 | Should we worry that take-home naloxone availability may increase opioid use? |
| Q34293294 | Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians |
| Q44670450 | Single- and multi-locus association tests incorporating phenotype heterogeneity |
| Q44073714 | Social networks as mediators of the effect of Alcoholics Anonymous |
| Q42939111 | Something must be done! But is Moore correct that something can be worse than nothing in alcohol control policy? |
| Q46830109 | State-Targeted Funding and Technical Assistance to Increase Access to Medication Treatment for Opioid Use Disorder. |
| Q91853170 | Still HOPEful: Reconsidering a "failed" replication of a swift, certain, and fair approach to reducing substance use among individuals under criminal justice supervision |
| Q36954731 | Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research. |
| Q37638326 | Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications |
| Q113272355 | Synthesizing advice to the United States from other nations that have experienced drug epidemics |
| Q51917211 | Testing association in the presence of linkage--a powerful score for binary traits. |
| Q43936210 | The Affordable Care Act will revolutionize care for substance use disorders in the United States |
| Q52316426 | The Opioid Epidemic as a Watershed Moment for Physician Training in Addiction Medicine. |
| Q58107971 | The Paucity of Attention to Narcotics Anonymous in Current Public, Professional, and Policy Responses to Rising Opioid Addiction |
| Q51033914 | The SNAP25 gene is linked to working memory capacity and maturation of the posterior cingulate cortex during childhood. |
| Q51147784 | The cost of concordance with opiate substitution treatment guidelines. |
| Q53382414 | The cost of institutional review board procedures in multicenter observational research. |
| Q38596255 | The exclusion of people with psychiatric disorders from medical research |
| Q21135294 | The genetic structure of the Swedish population |
| Q57568288 | The influence of mammographic density on breast tumor characteristics |
| Q48063263 | The liability risks of naloxone access expansion should be the least of our worries |
| Q57388315 | The need for more consistent evidential standards in cannabis policy evaluations |
| Q57265642 | The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant |
| Q40242599 | The psychological science of addiction |
| Q42615351 | The role of AA sponsors: a pilot study |
| Q52289234 | The trials of Alcoholics Anonymous. |
| Q40546472 | Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study |
| Q52280728 | Toward more responsive and effective intervention systems for alcohol-related problems. |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q35612485 | Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment |
| Q33800291 | Twelve-month follow-up results from a randomized controlled trial of a brief personalized feedback intervention for problem drinkers |
| Q33363454 | Ultra-brief intervention for problem drinkers: research protocol |
| Q34460836 | Ultra-brief intervention for problem drinkers: results from a randomized controlled trial |
| Q37205304 | Underrepresentation of African Americans in online cancer support groups. |
| Q60635189 | Validity and Reliability of the German Version of the Short Understanding of Substance Abuse Scale |
| Q44594921 | Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma |
| Q45332403 | Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness |
| Q44894949 | Vitamin D receptor genotypes, ultraviolet radiation exposure, and risk of non-Hodgkin lymphoma |
| Q42692136 | Volumetric mammographic density: heritability and association with breast cancer susceptibility loci |
| Q45995405 | Vote of thanks to Professor Tom Babor. |
| Q44337994 | Weighing the Risks and Benefits of Chronic Opioid Therapy |
| Q47676948 | What can treatment research offer general practice? |
| Q52300117 | What can we learn from the failure of yet another 'miracle cure' for addiction? |
| Q44350506 | What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality |
| Q48134337 | Who is responsible for the public's health? The role of the alcohol industry in the WHO global strategy to reduce the harmful use of alcohol |
| Q35195041 | Who uses online interventions for problem drinkers? |
| Q53086972 | Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy. |
| Q100737978 | Will hope triumph over experience in pharmacotherapy research on cocaine use disorder? |
| Q40638271 | Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross-sectional study |
| Q115254199 | Keith Humphreys | different from | P1889 |
| Category:Keith Humphreys | wikimedia | |
| Keith Humphreys | wikipedia |
Search more.